Why these 4 ASX shares are ending the week with a BANG

The Auscann Group Holdings Ltd (ASX:AC8) share price is one of four finishing the week strongly. Here's why these four shares are ending the week with a bang…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) is on course for a strong finish to the week. In afternoon trade the benchmark index is up 0.9% to 5,761 points thanks to gains in almost all sectors.

Four shares which have made notably strong gains today are listed below. Here's why they are finishing the week with a bang:

The Auscann Group Holdings Ltd (ASX: AC8) share price has jumped 5% to 75.5 cents as the pot stock rally continues to advance. With investors piling into the medical marijuana sector en masse, AusCann's shares have now climbed a remarkable 135% so far in March.

The Caltex Australia Limited (ASX: CTX) share price has climbed 4% to $29.41 despite there being no news out of the company. Today's gain is likely to be attributable to a research note out of Deutsche Bank. Its analysts reiterated their buy rating and increased their price target on its shares to $35.40 following a solid refiner margin update yesterday.

The Slater & Gordon Limited (ASX: SGH) share price has rocketed 20% to 13.2 cents after the embattled law firm announced that ASIC had concluded its investigation into the company's accounts. Following the investigation ASIC advised that there was no indication of a breach of law and it will not take any enforcement action.

The Syrah Resources Ltd (ASX: SYR) share price is up 6% to $2.75 after the graphite producer released an update on its Balama project. The update revealed that commissioning remains on schedule for the second quarter of 2017 and the capital budget remains unchanged at US$193 million. The project has suffered from significant delays in the past, but things finally appear to be going to plan.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »